Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for NewcelX Ltd. Common Shares, par value CHF 0.05 (NLSP).
- Disclosed ownership: 0.6%.
- Date of event: 31 Oct 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 0.6% ownership in NewcelX Ltd. Common Shares, par value CHF 0.05 (NLSP) on 31 Oct 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 0.3% | 15,196 | 0 | 15,196 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 0.3% | 15,196 | 0 | 15,196 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 0.3% | 11,746 | 0 | 11,746 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 0.3% | 11,746 | 0 | 11,746 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.03% | 1,334 | 0 | 1,334 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.03% | 1,334 | 0 | 1,334 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 0.6% | 26,942 | 0 | 26,942 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 0.6% | 28,732 | 0 | 28,732 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 0.6% | 28,732 | 0 | 28,732 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 0.6% | 28,732 | 0 | 28,732 | /s/ Mark N. Lampert | Mark N. Lampert |